CCDC62
Basic information
Region (hg38): 12:122774526-122827528
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Spermatogenic failure 67 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Genitourinary | 31985809 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (87 variants)
- not_provided (3 variants)
- Spermatogenic_failure_67 (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCDC62 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000201435.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | |||||
| missense | 84 | 88 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 0 | 84 | 4 | 3 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CCDC62 | protein_coding | protein_coding | ENST00000253079 | 12 | 53202 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 4.39e-16 | 0.155 | 125647 | 0 | 101 | 125748 | 0.000402 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.21 | 293 | 358 | 0.820 | 0.0000188 | 4530 |
| Missense in Polyphen | 99 | 133.79 | 0.73999 | 1698 | ||
| Synonymous | 0.442 | 135 | 142 | 0.953 | 0.00000843 | 1219 |
| Loss of Function | 1.16 | 28 | 35.5 | 0.790 | 0.00000173 | 454 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00122 | 0.00122 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00103 | 0.00103 |
| Finnish | 0.000324 | 0.000323 |
| European (Non-Finnish) | 0.000310 | 0.000308 |
| Middle Eastern | 0.00103 | 0.00103 |
| South Asian | 0.000362 | 0.000327 |
| Other | 0.000662 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Nuclear receptor coactivator that can enhance preferentially estrogen receptors ESR1 and ESR2 transactivation. Modulates also progesterone/PGR, glucocorticoid/NR3C1 and androgen/AR receptors transactivation, although at lower level; little effect on vitamin D receptor/VDR. {ECO:0000269|PubMed:19126643}.;
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- 0.918
- rvis_EVS
- 0.58
- rvis_percentile_EVS
- 82.3
Haploinsufficiency Scores
- pHI
- 0.111
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0902
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccdc62
- Phenotype
- reproductive system phenotype; cellular phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- blastocyst hatching;positive regulation of transcription by RNA polymerase II;cellular response to estradiol stimulus
- Cellular component
- nucleus;nucleoplasm;cytoplasm;plasma membrane
- Molecular function
- protein binding;estrogen receptor binding;nuclear receptor transcription coactivator activity